Last updated:
Author(s):
Robert F. Hillary, Danni A. Gadd, Zhana Kuncheva, Tasos Mangelis, Tinchi Lin, Kyle Ferber, Helen McLaughlin, Heiko Runz, Riccardo E. Marioni, Christopher N. Foley, Benjamin B. Sun
Publish date:
26 August 2024
Journal:
Nature Communications
PubMed ID:
39187491

Abstract

Understanding how gene-environment interactions (GEIs) influence the circulating proteome could aid in biomarker discovery and validation. The presence of GEIs can be inferred from single nucleotide polymorphisms that associate with phenotypic variability – termed variance quantitative trait loci (vQTLs). Here, vQTL association studies are performed on plasma levels of 1463 proteins in 52,363 UK Biobank participants. A set of 677 independent vQTLs are identified across 568 proteins. They include 67 variants that lack conventional additive main effects on protein levels. Over 1100 GEIs are identified between 101 proteins and 153 environmental exposures. GEI analyses uncover possible mechanisms that explain why 13/67 vQTL-only sites lack corresponding main effects. Additional analyses also highlight how age, sex, epistatic interactions and statistical artefacts may underscore associations between genetic variation and variance heterogeneity. This study establishes the most comprehensive database yet of vQTLs and GEIs for the human proteome.

Related projects

Overall success rates for bringing novel medicines to patients are low. Reasons for failure in drug discovery and clinical development are many and complex, including…

Institution:
GlaxoSmithKline, USA, United States of America

1. The primary scientific goal of the research is to apply human genetics to the identification of new drug targets, the validation of existing targets…

Institution:
Regeneron Genetics Center, LLC, United States of America

This project aims to study how a person’s genes affects the risk and progression of a broad range of diseases and medical conditions including cancer,…

Institution:
Genentech, Inc., United States of America

The aim of the proposed research is to understand comorbidities in cardiometabolic diseases. In particular, to answer the following questions: what are the biological mechanisms…

Institution:
Novo Nordisk Research Centre Oxford Ltd, Great Britain

The primary scientific goal of this research project is to apply multiplex proteomic profiling of 56,000 UK Biobank plasma samples to facilitate the identification of…

Institution:
Pfizer Inc, USA, United States of America

Whole genome sequencing of samples from the UK Biobank will lead to the identification of genetic variants within the human genome that can be associated…

Institution:
Amgen Inc, United States of America

All projects